Seeking Alpha

MissionIR's  Instablog

MissionIR
Send Message
We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices. It is our unwavering commitment to connect the investment community with companies that have great potential and a strong dedication to... More
My company:
MissionIR
My blog:
MissionIR Blog
  • GenMark Diagnostics, Inc. (GNMK) Announces Agreement With Advanced Liquid Logic To Develop An All-Electronic, Fully Integrated Diagnostic Platform 0 comments
    Apr 5, 2012 6:12 PM | about stocks: GNMK

    Today, GenMark Diagnostics announced it has entered into a heads of agreement with Advanced Liquid Logic (ALL) defining the key terms of a collaboration between the two companies. GenMark and ALL will co-develop an all-electronic, fully integrated in-vitro diagnostic platform that unites ALL's proprietary electrowetting technology with GenMark's proprietary electrochemical detection.

    The partnership will leverage the unique technologies and capabilities of both companies, delivering a digital sample-to-answer in-vitro diagnostic platform. The initial focus will be on multiplex molecular testing, followed by efforts in other diagnostics areas such as protein detection and point-of-care testing. The companies anticipate these efforts will redefine industry performance standards for even the most complex assays.

    GenMark Diagnostics is an industry leader in providing automated, multiplex molecular diagnostic testing systems that detect and measure DNA and RNA targets for the diagnosis of disease and the optimization of patient treatment. Utilizing the company's proprietary eSensor detection technology, GenMark's eSensor XT-8 system supports a wide range of molecular diagnostics tests with a compact, user-friendly workstation and self-contained, disposable test cartridges. GenMark currently markets three FDA-cleared tests for IVD use. A respiratory viral panel (RVP) has been submitted for 510(k) clearance by the FDA, and a number of other tests are presently in development for IVD use.

    For more information, visit the company's Web site at www.genmarkdx.com

    Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

    Stocks: GNMK
Back To MissionIR's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.